Enos Bernasconi to Prospective Studies
This is a "connection" page, showing publications Enos Bernasconi has written about Prospective Studies.
Connection Strength
0.105
-
Diabetes mellitus is a risk factor for prolonged SARS-CoV-2 viral shedding in lower respiratory tract samples of critically ill patients. Endocrine. 2020 12; 70(3):454-460.
Score: 0.036
-
SARS-CoV-2 detection in the lower respiratory tract of invasively ventilated ARDS patients. Crit Care. 2020 10 16; 24(1):610.
Score: 0.009
-
Incidence of hepatocellular carcinoma in HIV/HBV-coinfected patients on tenofovir therapy: Relevance for screening strategies. J Hepatol. 2019 08; 71(2):274-280.
Score: 0.008
-
Interferon lambda 3/4 polymorphisms are associated with AIDS-related Kaposi's sarcoma. AIDS. 2018 11 28; 32(18):2759-2765.
Score: 0.008
-
Long-term Immune Response to Yellow Fever Vaccination in Human Immunodeficiency Virus (HIV)-Infected Individuals Depends on HIV RNA Suppression Status: Implications for Vaccination Schedule. Clin Infect Dis. 2018 03 19; 66(7):1099-1108.
Score: 0.008
-
Adverse events of raltegravir and dolutegravir. AIDS. 2017 08 24; 31(13):1853-1858.
Score: 0.007
-
Trends in HCV treatment uptake, efficacy and impact on liver fibrosis in the Swiss HIV Cohort Study. Liver Int. 2018 03; 38(3):424-431.
Score: 0.007
-
Rilpivirine use in the Swiss HIV cohort study: a prospective cohort study. BMC Infect Dis. 2017 07 06; 17(1):476.
Score: 0.007
-
Human papillomavirus antibody response following HAART initiation among MSM. AIDS. 2017 02 20; 31(4):561-569.
Score: 0.007
-
High prevalence of physical inactivity among patients from the Swiss HIV Cohort Study. AIDS Care. 2017 08; 29(8):1056-1061.
Score: 0.007